Rodney Kelly Joins HekaBio as Chief Growth Officer April 1, 2025

April 1st

Rodney Kelly Joins HekaBio as Chief Growth Officer

HekaBio has announced the appointment of Rodney Kelly as its new Chief Growth Officer. In this role, Rodney will be responsible for driving the company’s growth strategy through new asset search & evaluation and expansion in Asia Pacific.

About Rodney Kelly

Rodney has extensive international experience in health innovation, with a strong emphasis on improving patient outcomes and enabling market access across the UK, Japan, and Southeast Asia. He supports health and life sciences ventures through clinical validation, regulatory navigation, and global expansion, helping them align with local healthcare system demands.

HekaBio's Mission

HekaBio aims to accelerate patient access to world-leading healthcare solutions. With Rodney on board, the company is poised to bring more life-changing choices for healthy longevity in Japan and Asia Pacific.

Read Rodney's full profile from here